ImageneBio Inc(IMA)

Biotechnology · San Diego, CA

$4.77+0.07 (+1.49%)

Delayed quote: Oct 6, 2026, 11:38 AM EDT

EV/FCF Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/FCF ratio is N/A as of 2026-10-06T15:42:17.749Z.

Stored calculation inputs

Calculation as of: 2026-10-06T15:42:17.749Z.

Quote observation: 2026-10-06T15:38:30.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 53,801,307
Total debt · period ending 2026-06-30: 1,912,000
Cash · period ending 2026-06-30: 94,677,000
TTM free cash flow · period ending 2026-06-30: -57,733,000

FMP input reference: 3f3fe5cfad96663d45aee285232b63282d401ce5a2dce1ebe999e7f7af3a8937

Free Cash Flow|FCF Yield|P/FCF Ratio|EV/EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

IMA EV/FCF Ratio Metrics

EV/FCF RATIO

N/A

IMA Competitors' EV/FCF Ratio

IMA

ImageneBio Inc

Current

Market Cap

$53.80M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALDX

Aldeyra The

vs IMA

Market Cap

$54.53M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MDAI

Spectral AI, Inc.

vs IMA

Market Cap

$55.08M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NMAD

NOMAD Power Solutions, Inc.

vs IMA

Market Cap

$51.99M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

EXOZ

eXoZymes, Inc.

vs IMA

Market Cap

$51.98M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ELOX

Eloxx Pharmaceuticals, Inc.

vs IMA

Market Cap

$52.61M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BTMD

biote Corp.

vs IMA

Market Cap

$50.28M

EV/FCF Ratio

8.52x

TTM Avg

5.77x

3Y Avg

8.01x

5Y Avg

6.98x

DWTX

Dogwood Therapeutics, Inc.

vs IMA

Market Cap

$52.46M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

APLM

Apollomics, Inc.

vs IMA

Market Cap

$51.39M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MBOT

Microbot Medical Inc.

vs IMA

Market Cap

$51.27M

EV/FCF Ratio

N/A

TTM Avg

12.79x

3Y Avg

13.79x

5Y Avg

13.79x

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
ImageneBio Inc (IMA)	$53.80M	N/A	N/A	N/A	N/A
Aldeyra The (ALDX)vs ›	$54.53M	N/A	N/A	N/A	N/A
Spectral AI, Inc. (MDAI)vs ›	$55.08M	N/A	N/A	N/A	N/A
NOMAD Power Solutions, Inc. (NMAD)vs ›	$51.99M	N/A	N/A	N/A	N/A
eXoZymes, Inc. (EXOZ)vs ›	$51.98M	N/A	N/A	N/A	N/A
Eloxx Pharmaceuticals, Inc. (ELOX)vs ›	$52.61M	N/A	N/A	N/A	N/A
biote Corp. (BTMD)vs ›	$50.28M	8.52x	5.77x	8.01x	6.98x
Dogwood Therapeutics, Inc. (DWTX)vs ›	$52.46M	N/A	N/A	N/A	N/A
Apollomics, Inc. (APLM)vs ›	$51.39M	N/A	N/A	N/A	N/A
Microbot Medical Inc. (MBOT)vs ›	$51.27M	N/A	12.79x	13.79x	13.79x

Cash Flow Valuation Comparison

EV/FCF

N/A

P/FCF

N/A

FCF Yield

N/A

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

EV/FCF accounts for debt and cash through enterprise value
P/FCF only considers equity value
EV/FCF can be compared across companies with different debt levels
Both measure how the market values cash generation

EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/FCF Ratio: N/A

IMA EV/FCF Ratio Metrics

IMA Competitors' EV/FCF Ratio

Cash Flow Valuation Comparison

EV/FCF Ratio Formula & Definition

Related Metrics